Company filings profile · CIK 0001505497
BioRestorative Therapies, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for BioRestorative Therapies, Inc. (BRTX): 12 filings in the last 90 days vs 15 in the prior 90 (filing-velocity cooling ↓ · 0.8×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 10, 2026. Source-linked, daily-refreshed.
Material 8-K events — BioRestorative Therapies, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 9, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Sep 11, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Sep 2, 2026 | Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 2, 2026 | Change in Auditor; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 25, 2026 | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 16, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 12, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 12, 2026 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 1, 2026 | Departure/Election of Directors or Officers | ↗ |
| Apr 23, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch BioRestorative Therapies, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 9, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Sep 11, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Sep 10, 2026 | 8-K/A | Change in Auditor; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 2, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 2, 2026 | 8-K | Change in Auditor; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 25, 2026 | 8-K | Delisting / Listing-Rule Failure; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | NT 10-Q | NT 10-Q | ↗ |
| Aug 14, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 30, 2026 | 3 | ↗ | |
| Jul 24, 2026 | 3 | PRIMARY DOCUMENT | ↗ |
| Jul 16, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | 3 | ↗ | |
| Jun 18, 2026 | 3 | ↗ | |
| Jun 17, 2026 | 3 | ↗ | |
| Jun 12, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 12, 2026 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 29, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 1, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Apr 30, 2026 | 424B3 | 424B3 | ↗ |
| Apr 28, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 27, 2026 | POS AM | POS AM | ↗ |
| Apr 23, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 20, 2026 | POS AM | POS AM | ↗ |
| Apr 13, 2026 | DEF 14A | ↗ | |
| Apr 3, 2026 | PRE 14A | PRELIMINARY PROXY STATEMENT NOT RELATED TO A CONTESTED MATTER OR MERGER/ACQUISIT | ↗ |
| Mar 26, 2026 | 10-K | 10-K | ↗ |
| Feb 23, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 18, 2026 | SCHEDULE 13G | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 13, 2026 | SCHEDULE 13G | ↗ | |
| Feb 13, 2026 | 424B4 | 424B4 | ↗ |
| Feb 11, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Feb 10, 2026 | CORRESP | ↗ | |
| Feb 10, 2026 | S-1/A | S-1/A | ↗ |
| Feb 9, 2026 | S-1 | S-1 | ↗ |
| Dec 19, 2025 | DRS | ↗ |